
GeneTex Affinity Purified anti-Human SFRP1 antibody (GTX24193) was used at a 1:800 dilution for 20 min to detect SFRP in human dermal hypertrophic scar tissue. Tissue was formalin-fixed followed by heat mediated antigen retrieval prior to blocking. HRP Gt-a-Rabbit IgG (GTX26721) is suitable for secondary antibody detection.
SFRP1 antibody
GTX24193
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetSFRP1
Overview
- SupplierGeneTex
- Product NameSFRP1 antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:200-1:2000. ICC/IF: 5 microg/mL. IHC-P: 1:800. ELISA: 1:5000-1:15000. IHC: 1:800. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- ConjugateUnconjugated
- Gene ID6422
- Target nameSFRP1
- Target descriptionsecreted frizzled related protein 1
- Target synonymsfrizzled-related protein; FRP; FRP1; FRP-1; FrzA; SARP2; SARP-2; secreted apoptosis-related protein 2; secreted frizzled-related protein 1; sFRP-1
- HostRabbit
- IsotypeIgG
- Protein IDQ8N474
- Protein NameSecreted frizzled-related protein 1
- Scientific DescriptionSFRP1 is a member of the SFRP family that contains a cysteine-rich domain homologous to the putative Wnt-binding site of Frizzled proteins. SFRPs act as soluble modulators of Wnt signaling. SFRP1 and SFRP5 may be involved in determining the polarity of photoreceptor cells in the retina. SFRP1 is expressed in several human tissues, with the highest levels in heart.
- ReactivityHuman
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Increased expression of secreted frizzled related protein 1 (SFRP1) predicts ampullary adenocarcinoma recurrence. Cheng LC et al., 2020 Aug 6, Sci RepRead more